3C Patch for treating diabetic foot ulcers
Closed for comments This consultation ended on at Request commenting lead permission
1 Recommendations
1.1 The case for adopting 3C Patch for diabetic foot ulcers is not supported. Cost modelling shows that using 3C Patch is unlikely to lead to savings.
Why the committee made these recommendations
Diabetic foot ulcers are treated by reducing pressure on the ulcer, removing damaged tissue, controlling poor blood flow and using dressings, including UrgoStart or other advanced dressings. The 3C Patch system uses a person's own blood to create a biological patch that promotes wound healing. It is intended to be used for diabetic foot ulcers that have not healed after 4 weeks of treatment.
The clinical evidence on ulcers that are not healing shows that using 3C Patch led to more ulcers healing at 20 weeks and faster ulcer healing. But, cost analysis for 3C Patch showed that the clinical benefits seen in the trial are unlikely to lead to cost savings in practice. Therefore 3C Patch cannot be recommended.
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions
Question on Consultation
Question on Consultation
Question on Consultation
Question on Consultation